![Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-021-02985-6/MediaObjects/262_2021_2985_Fig2_HTML.png)
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
![PDF) Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: A Hellenic Cooperative Oncology Group (HeCOG) study PDF) Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: A Hellenic Cooperative Oncology Group (HeCOG) study](https://i1.rgstatic.net/publication/24442165_Randomized_multicenter_phase_II_trial_of_cisplatin_and_ifosfamide_with_or_without_paclitaxel_in_recurrent_or_metastatic_carcinoma_of_the_uterine_cervix_A_Hellenic_Cooperative_Oncology_Group_HeCOG_stud/links/564cdf9108ae1ef9296a5691/largepreview.png)
PDF) Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: A Hellenic Cooperative Oncology Group (HeCOG) study
![PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab](https://i1.rgstatic.net/publication/328500699_144PCyclin_D1_differential_activation_and_its_prognostic_impact_among_advanced_breast_cancer_patients_treated_with_trastuzumab/links/5bd1bb54299bf14eac844c4e/largepreview.png)
PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab
![PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with](https://i1.rgstatic.net/publication/354211763_An_Observational_Study_to_Assess_the_Molecular_Epidemiology_and_Direct_Medical_Costs_of_Epidermal_Growth_Factor_Receptor_EGFR_Mutations_in_Patients_with_Advanced_EGFR_Mutation-Positive_Non-Small_Cell_/links/612d0fff38818c2eaf7015f4/largepreview.png)
PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with
![Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5f6dda9af5627cefa2f77f6994970b3e880e87b6/4-Figure3-1.png)
Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar
![PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy](https://www.researchgate.net/profile/Giannis-Mountzios/publication/272095123/figure/fig1/AS:616389287096335@1523970066954/figure-fig1_Q320.jpg)
PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy
![PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia](https://i1.rgstatic.net/publication/285750382_Lessons_from_the_past_Long-term_safety_and_survival_outcomes_of_a_prematurely_terminated_randomized_controlled_trial_on_prophylactic_vs_hemoglobin-based_administration_of_erythropoiesis-stimulating_ag/links/56effbd908ae3c653436607d/largepreview.png)
PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia
![Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-021-02985-6/MediaObjects/262_2021_2985_Fig1_HTML.png)
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
![PDF) Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature PDF) Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature](https://i1.rgstatic.net/publication/236676185_Adrenal_Incidentalomas_in_Cancer_Patients_Are_Not_Always_Innocent_A_Case_Report_and_Review_of_the_Literature/links/0deec52795dc442055000000/largepreview.png)
PDF) Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
![PDF) Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group PDF) Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group](https://i1.rgstatic.net/publication/352703088_Real-world_safety_and_efficacy_data_of_immunotherapy_in_patients_with_cancer_and_autoimmune_disease_the_experience_of_the_Hellenic_Cooperative_Oncology_Group/links/60d41222a6fdcc75a24e0966/largepreview.png)
PDF) Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
![PDF) Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer | Christos Alamanis and Christos Papadimitriou - Academia.edu PDF) Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer | Christos Alamanis and Christos Papadimitriou - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45405093/mini_magick20190212-11828-9hp085.png?1549975070)
PDF) Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer | Christos Alamanis and Christos Papadimitriou - Academia.edu
![PDF) REVIEW Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy PDF) REVIEW Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy](https://i1.rgstatic.net/publication/26648417_REVIEW_Excision_Repair_Cross-Complementation_Group_1_Enzyme_as_a_Molecular_Determinant_of_Responsiveness_to_Platinum-Based_Chemotherapy/links/00463524fc7c741839000000/largepreview.png)
PDF) REVIEW Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy
![PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy](https://i1.rgstatic.net/publication/272095123_Optimal_management_of_the_elderly_patient_with_head_and_neck_cancer_Issues_regarding_surgery_irradiation_and_chemotherapy/links/550ebfa40cf27526109e6dc0/largepreview.png)
PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy
![PDF) Current and Emerging Roles of Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small Cell Lung Cancer PDF) Current and Emerging Roles of Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small Cell Lung Cancer](https://i1.rgstatic.net/publication/228772479_Current_and_Emerging_Roles_of_Epidermal_Growth_Factor_Receptor_Inhibitors_in_Advanced_Non-Small_Cell_Lung_Cancer/links/004635174d52b87465000000/largepreview.png)
PDF) Current and Emerging Roles of Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small Cell Lung Cancer
![PDF) Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: Real-world data from PDF) Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: Real-world data from](https://i1.rgstatic.net/publication/338296760_Outcomes_from_salvage_chemotherapy_or_pembrolizumab_beyond_progression_with_or_without_local_ablative_therapies_for_advanced_non-small_cell_lung_cancers_with_PD-L1_50_who_progress_on_first-line_immuno/links/5e43e1c6458515072d9372a2/largepreview.png)